Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Atara Biotherapeutics, Inc. (ATRA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0.2% stake in Atara Biotherapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| MAVERICK CAPITAL LTD reports a 6.6% stake in Atara Biotherapeutics, Inc. |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 7.6% stake in Atara Biotherapeutics Inc. |
| 02/09/2023 |
SC 13G/A
| FMR LLC reports a 0.1% stake in ATARA BIOTHERAPEUTICS INC |
| 01/18/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/11/2022 |
SC 13G/A
| MAVERICK CAPITAL LTD reports a 8.4% stake in Atara Biotherapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Atara Biotherapeutics, Inc. reports a 8.9% stake in Atara Biotherapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in ATARA BIOTHERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 5.2% stake in Atara Biotherapeutics, Inc. |
| 02/09/2022 |
SC 13G/A
| Baupost Group reports a 9.2% stake in Atara Biotherapeutics, Inc. |
| 02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/07/2022 |
SC 13G/A
| JPMORGAN CHASE & CO reports a 8.3% stake in ATARA BIOTHERAPEUTICS, INC. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 8.5% stake in ATARA BIOTHERAPEUTICS INC |
| 08/12/2019 |
SC 13G/A
| FMR LLC reports a 4.6% stake in ATARA BIOTHERAPEUTICS INC ? |
| 02/14/2019 |
SC 13G/A
| BRIDGER MANAGEMENT, LLC reports a 4.8% stake in Atara Biotherapeutics, Inc. |
| 02/14/2019 |
SC 13G/A
| Redmile Group, LLC reports a 9.7% stake in Atara Biotherapeutics, Inc. |
| 02/14/2019 |
SC 13G/A
| Kleiner Perkins Caufield & Byers XV, LLC reports a 4.1% stake in Atara Biotherapeutics, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| FMR LLC reports a 11.6% stake in ATARA BIOTHERAPEUTICS INC |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|